These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 20183160)

  • 1. Risk of tumorigenesis in first-in-human trials of embryonic stem cell neural derivatives: Ethics in the face of long-term uncertainty.
    Hess PG
    Account Res; 2009 Jul; 16(4):175-98. PubMed ID: 20183160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caution urged in trial of stem cells to treat spinal-cord injury.
    Barde Y
    Nature; 2009 Mar; 458(7234):29. PubMed ID: 19262651
    [No Abstract]   [Full Text] [Related]  

  • 3. Cell-based interventions for neurologic conditions: ethical challenges for early human trials.
    Mathews DJ; Sugarman J; Bok H; Blass DM; Coyle JT; Duggan P; Finkel J; Greely HT; Hillis A; Hoke A; Johnson R; Johnston M; Kahn J; Kerr D; Kurtzberg J; Liao SM; McDonald JW; McKhann G; Nelson KB; Rao M; Regenberg A; Siegel AW; Smith K; Solter D; Song H; Vescovi A; Young W; Gearhart JD; Faden R
    Neurology; 2008 Jul; 71(4):288-93. PubMed ID: 18463365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GRNOPC1: the world's first embryonic stem cell-derived therapy. Interview with Jane Lebkowski.
    Lebkowski J
    Regen Med; 2011 Nov; 6(6 Suppl):11-3. PubMed ID: 21999256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biotechnology. Celebration and concern over U.S. trial of embryonic stem cells.
    Couzin J
    Science; 2009 Jan; 323(5914):568. PubMed ID: 19179496
    [No Abstract]   [Full Text] [Related]  

  • 6. Human embryonic stem cell-derived oligodendrocyte progenitors for the treatment of spinal cord injury.
    Faulkner J; Keirstead HS
    Transpl Immunol; 2005 Dec; 15(2):131-42. PubMed ID: 16412957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical research with healthy volunteers: an ethical framework.
    Miller FG
    J Investig Med; 2003 Feb; 51 Suppl 1():S2-5. PubMed ID: 12664947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical trials in stem cell transplantation: guidelines for scientific and ethical review.
    Lo B; Kriegstein A; Grady D
    Clin Trials; 2008; 5(5):517-22. PubMed ID: 18827044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uncertain translation, uncertain benefit and uncertain risk: ethical challenges facing first-in-human trials of induced pluripotent stem (ips) cells.
    Fung RK; Kerridge IH
    Bioethics; 2013 Feb; 27(2):89-96. PubMed ID: 21726264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Target populations for first-in-human embryonic stem cell research in spinal cord injury.
    Bretzner F; Gilbert F; Baylis F; Brownstone RM
    Cell Stem Cell; 2011 May; 8(5):468-75. PubMed ID: 21549321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Translation of stem cell therapy for neurological diseases.
    Schwarz SC; Schwarz J
    Transl Res; 2010 Sep; 156(3):155-60. PubMed ID: 20801412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Stem cell therapy for neurodegenerative disorders].
    Meyer M; Jensen P; Rasmussen JZ
    Ugeskr Laeger; 2010 Sep; 172(38):2604-7. PubMed ID: 20920404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First patient enters trial to test safety of stem cells in spinal injury.
    Mayor S
    BMJ; 2010 Oct; 341():c5724. PubMed ID: 20940208
    [No Abstract]   [Full Text] [Related]  

  • 14. A new era in the ethics of human embryonic stem cell research.
    Lo B; Zettler P; Cedars MI; Gates E; Kriegstein AR; Oberman M; Reijo Pera R; Wagner RM; Wuerth MT; Wolf LE; Yamamoto KR
    Stem Cells; 2005; 23(10):1454-9. PubMed ID: 16293581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Umbilical cord blood-derived stem cells and brain repair.
    Sanberg PR; Willing AE; Garbuzova-Davis S; Saporta S; Liu G; Sanberg CD; Bickford PC; Klasko SK; El-Badri NS
    Ann N Y Acad Sci; 2005 May; 1049():67-83. PubMed ID: 15965108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is risky pediatric research without prospect of direct benefit ever justified?
    Martin RA; Robert JS
    Am J Bioeth; 2007 Mar; 7(3):12-5. PubMed ID: 17366221
    [No Abstract]   [Full Text] [Related]  

  • 17. Adult human neural stem cells for autologous cell replacement therapies for neurodegenerative disorders.
    Galvin KA; Jones DG
    NeuroRehabilitation; 2006; 21(3):255-65. PubMed ID: 17167195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP Panel: clinical trial inclusion/exclusion criteria and ethics.
    Tuszynski MH; Steeves JD; Fawcett JW; Lammertse D; Kalichman M; Rask C; Curt A; Ditunno JF; Fehlings MG; Guest JD; Ellaway PH; Kleitman N; Bartlett PF; Blight AR; Dietz V; Dobkin BH; Grossman R; Privat A;
    Spinal Cord; 2007 Mar; 45(3):222-31. PubMed ID: 17179971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethical reflections on clinical trials with human tissue engineered products.
    Trommelmans L; Selling J; Dierickx K
    J Med Ethics; 2008 Sep; 34(9):e1. PubMed ID: 18757609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cotransplantation of mouse embryonic stem cells and bone marrow stromal cells following spinal cord injury suppresses tumor development.
    Matsuda R; Yoshikawa M; Kimura H; Ouji Y; Nakase H; Nishimura F; Nonaka J; Toriumi H; Yamada S; Nishiofuku M; Moriya K; Ishizaka S; Nakamura M; Sakaki T
    Cell Transplant; 2009; 18(1):39-54. PubMed ID: 19476208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.